Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
The pneumococcal 15-valent conjugate vaccine (PCV15), known by the brand name Vaxneuvance, protects individuals aged 6 weeks and older against invasive pneumococcal disease and pneumonia caused by 15 specific strains of Streptococcus pneumoniae bacteria
The pneumococcal 15-valent conjugate vaccine (PCV15), known by the brand name Vaxneuvance, protects individuals aged 6 weeks and older against invasive pneumococcal disease and pneumonia caused by 15 specific strains of Streptococcus pneumoniae bacteria